Insight Molecular Diagnostics Inc. (IMDX) Operating cash flow 2016–2025
Insight Molecular Diagnostics Inc. (IMDX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$22.2MFY2025 · since FY2016: -$7.5M → -$22.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$22.2M | -7.2% |
| FY2024 | -$20.7M | +11.3% |
| FY2023 | -$23.3M | +48.8% |
| FY2022 | -$45.6M | -26.8% |
| FY2021 | -$35.9M | -38.3% |
| FY2020 | -$26.0M | -31.8% |
| FY2019 | -$19.7M | -69.2% |
| FY2018 | -$11.6M | +13.0% |
| FY2017 | -$13.4M | -77.9% |
| FY2016 | -$7.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More IMDX financial trends
IMDX RevenueIMDX Net incomeIMDX Net marginIMDX Gross profitIMDX Gross marginIMDX Operating incomeIMDX Operating marginIMDX Free cash flowIMDX Capital expendituresIMDX Return on equityIMDX Stock buybacksIMDX Dividends paidIMDX Total assetsIMDX Total liabilitiesIMDX Shareholders’ equityIMDX overview →